High eomesodermin expression among CD57+ CD8+ T cells identifies a CD8+ T cell subset associated with viral control during chronic human immunodeficiency virus infection

Journal of Virology

Volumn 88, Issue 20, 2014, Pages 11861-11871

  Simonetta, Federico ^a,b,c   Hua, Stéphane ^a,b   Lécuroux, Camille ^a,b   Gérard, Sandie ^a,b   Boufassa, Faroudy ^d   Sáez Cirión, Asier ^e   Pancino, Gianfranco ^e   Goujard, Cécile ^b,f   Lambotte, Olivier ^a,b,f   Venet, Alain ^a,b   Bourgeois, Christine ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^e INSTITUT PASTEUR   (France)

^f BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD57 ANTIGEN; EOMESODERMIN; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR T BET; EOMES PROTEIN, HUMAN; T BOX TRANSCRIPTION FACTOR;

ADULT; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; CD8+ T LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; VIREMIA; VIRUS LOAD; IMMUNOLOGY; METABOLISM; MIDDLE AGED; VIROLOGY;

ADULT; ANTIGENS, CD57; CD8-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HUMANS; MIDDLE AGED; T-BOX DOMAIN PROTEINS;

EID: 84907911692     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02013-14     Document Type: Article

References (32)

1. Brenchley JM, Karandikar NJ, Betts MR, Ambrozak DR, Hill BJ, Crotty LE, Casazza JP, Kuruppu J, Migueles SA, Connors M, Roederer M, Douek DC, Koup RA. 2003. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101:2711-2720. http://dx.doi.org/10.1182/blood-2002-07-2103.
2. Lichterfeld M, Mou D, Cung TDH, Williams KL, Waring MT, Huang J, Pereyra F, Trocha A, Freeman GJ, Rosenberg ES, Walker BD, Yu XG. 2008. Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors. Blood 112:3679-3687. http://dx.doi.org/10.1182 /blood-2008-01-135442.
3. Lambotte O, Boufassa F, Madec Y, Nguyen A, Goujard C, Meyer L, Rouzioux C, Venet A, Delfraissy JF. 2005. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin. Infect. Dis. 41:1053-1056. http://dx.doi.org/10.1086 /433188.
4. Card CM, Keynan Y, Lajoie J, Bell CP, Dawood M, Becker M, Kasper K, Fowke KR. 2012. HIV controllers are distinguished by chemokine expression profile and HIV-specific T-cell proliferative potential. J. Acquir. Immune Defic. Syndr. 59:427-437. http://dx.doi.org/10.1097/QAI.0b013e3182454fcd.
5. Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, Hallahan CW, Van Baarle D, Kostense S, Miedema F, McLaughlin M, Ehler L, Metcalf J, Liu S, Connors M. 2002. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3:1061-1068. http://dx.doi.org/10.1038/ni845.
6. Zimmerli SC, Harari A, Cellerai C, Vallelian F, Bart PA, Pantaleo G. 2005. HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc. Natl. Acad. Sci. U. S. A. 102:7239-7244. http://dx.doi.org/10.1073/pnas.0502393102.
7. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, Lederman MM, Benito JM, Goepfert PA, Connors M, Roederer M, Koup RA. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107:4781-4789. http://dx.doi.org/10.1182/blood-2005-12-4818.
8. Hersperger AR, Pereyra F, Nason M, Demers K, Sheth P, Shin LY, Kovacs CM, Rodriguez B, Sieg SF, Teixeira-Johnson L, Gudonis D, Goepfert PA, Lederman MM, Frank I, Makedonas G, Kaul R, Walker BD, Betts MR. 2010. Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog. 6:e1000917. http://dx.doi.org/10.1371/journal.ppat.1000917.
9. Le Priol Y, Puthier D, Lecureuil C, Combadiere C, Debre P, Nguyen C, Combadiere B, Lécureuil C, Combadière C, Debré P, Combadière B. 2006. High cytotoxic and specific migratory potencies of senescent CD8+ CD57+ cells in HIV-infected and uninfected individuals. J. Immunol. 177:5145-5154. http://dx.doi.org/10.4049/jimmunol.177.8.5145.
10. Papagno L, Spina CA, Marchant A, Salio M, Rufer N, Little S, Dong T, Chesney G, Waters A, Easterbrook P, Dunbar PR, Shepherd D, Cerundolo V, Emery V, Griffiths P, Conlon C, McMichael AJ, Richman DD, Rowland-Jones SL, Appay V. 2004. Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol. 2:E20. http://dx.doi.org/10.1371/journal.pbio.0020020.
11. Petrovas C, Chaon B, Ambrozak DR, Price DA, Melenhorst JJ, Hill BJ, Geldmacher C, Casazza JP, Chattopadhyay PK, Roederer M, Douek DC, Mueller YM, Jacobson JM, Kulkarni V, Felber BK, Pavlakis GN, Katsikis PD, Koup RA. 2009. Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. J. Immunol. 183:1120-1132. http://dx.doi.org/10.4049/jimmunol.0900182.
12. Lewis DE, Puck JM, Babcock GF, Rich RR. 1985. Disproportionate expansion of a minor T cell subset in patients with lymphadenopathy syndrome and acquired immunodeficiency syndrome. J. Infect. Dis. 151: 555-559. http://dx.doi.org/10.1093/infdis/151.3.555.
13. Chattopadhyay PK, Betts MR, Price DA, Gostick E, Horton H, Roederer M, De Rosa SC. 2009. The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression. J. Leukoc. Biol. 85:88-97. http://dx.doi.org/10.1189/jlb.0208107.
14. Lee SA, Sinclair E, Hatano H, Hsue PY, Epling L, Hecht FM, Bangsberg DR, Martin JN, McCune JM, Deeks SG, Hunt PW. 2014. Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging. PLoS One 9:e89444. http://dx.doi.org/10.1371/journal.pone.0089444.
15. Lee SA, Sinclair E, Jain V, Huang Y, Epling L, Van Natta M, Meinert CL, Martin JN, McCune JM, Deeks SG, Lederman MM, Hecht FM, Hunt PW. 2014. Low proportions of CD28-CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection. J. Infect. Dis. 210:372-382. http://dx.doi.org/10.1093/infdis/jiu109.
16. Cruz-Guilloty F, Pipkin ME, Djuretic IM, Levanon D, Lotem J, Lichtenheld MG, Groner Y, Rao A. 2009. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J. Exp. Med. 206:51-59. http://dx.doi.org/10.1084/jem.20081242.
17. Intlekofer AM, Banerjee A, Takemoto N, Gordon SM, Dejong CS, Shin H, Hunter CA, Wherry EJ, Lindsten T, Reiner SL. 2008. Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 321:408-411. http://dx.doi.org/10.1126/science.1159806.
18. Pearce EL, Mullen AC, Martins GA, Krawczyk CM, Hutchins AS, Zediak VP, Banica M, DiCioccio CB, Gross DA, Mao CA, Shen H, Cereb N, Yang SY, Lindsten T, Rossant J, Hunter CA, Reiner SL. 2003. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 302:1041-1043. http://dx.doi.org/10.1126/science.1090148.
19. Banerjee A, Gordon SM, Intlekofer AM, Paley MA, Mooney EC, Lindsten T, Wherry EJ, Reiner SL. 2010. Cutting edge: the transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche. J. Immunol. 185:4988-4992. http://dx.doi.org/10.4049/jimmunol.1002042.
20. Intlekofer AM, Takemoto N, Wherry EJ, Longworth SA, Northrup JT, Palanivel VR, Mullen AC, Gasink CR, Kaech SM, Miller JD, Gapin L, Ryan K, Russ AP, Lindsten T, Orange JS, Goldrath AW, Ahmed R, Reiner SL. 2005. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6:1236-1244. http://dx.doi.org/10.1038/ni1268.
21. Rao RR, Li Q, Odunsi K, Shrikant PA. 2010. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity 32:67-78. http://dx.doi.org/10.1016/j.immuni.2009.10.010.
22. Intlekofer AM, Takemoto N, Kao C, Banerjee A, Schambach F, Northrop JK, Shen H, Wherry EJ, Reiner SL. 2007. Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells. J. Exp. Med. 204:2015-2021. http://dx.doi.org/10.1084/jem.20070841.
23. Joshi NS, Cui W, Chandele A, Lee HK, Urso DR, Hagman J, Gapin L, Kaech SM. 2007. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27:281-295. http://dx.doi.org/10.1016/j.immuni.2007.07.010.
24. McLane LM, Banerjee PP, Cosma GL, Makedonas G, Wherry EJ, Orange JS, Betts MR. 2013. Differential localization of T-bet and Eomes in CD8 T cell memory populations. J. Immunol. 190:3207-3215. http://dx.doi.org/10.4049/jimmunol.1201556.
25. Paley MA, Kroy DC, Odorizzi PM, Johnnidis JB, Dolfi DV, Barnett BE, Bikoff EK, Robertson EJ, Lauer GM, Reiner SL, Wherry EJ. 2012. Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science 338:1220-1225. http://dx.doi.org/10.1126 /science.1229620.
26. Hasley RB, Hong C, Li W, Friesen T, Nakamura Y, Kim GY, Park J-H, Hixon JA, Durum S, Hu Z, Sneller MC, Oguariri R, Imamichi T, Lane HC, Catalfamo M. 2013. HIV immune activation drives increased Eomes expression in memory CD8 T cells in association with transcriptional downregulation of CD127. AIDS 27:1867-1877. http://dx.doi.org/10.1097/QAD.0b013e3283618487.
27. Ribeiro-dos-Santos P, Turnbull EL, Monteiro M, Legrand A, Conrod K, Baalwa J, Pellegrino P, Shaw GM, Williams I, Borrow P, Rocha B. 2012. Chronic HIV infection affects the expression of the 2 transcription factors required for CD8 T-cell differentiation into cytolytic effectors. Blood 119: 4928-4938. http://dx.doi.org/10.1182/blood-2011-12-395186.
28. Dolfi DV, Mansfield KD, Polley AM, Doyle SA, Freeman GJ, Pircher H, Schmader KE, Wherry EJ. 2013. Increased T-bet is associated with senescence of influenza virus-specific CD8 T cells in aged humans. J. Leukoc. Biol. 93:825-836. http://dx.doi.org/10.1189/jlb.0912438.
29. Sullivan BM, Juedes A, Szabo SJ, von Herrath M, Glimcher LH. 2003. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl. Acad. Sci. U. S. A. 100:15818-15823. http://dx.doi.org/10.1073/pnas.2636938100.
30. Hersperger AR, Martin JN, Shin LY, Sheth PM, Kovacs CM, Cosma GL, Makedonas G, Pereyra F, Walker BD, Kaul R, Deeks SG, Betts MR. 2011. Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression. Blood 117:3799-3808. http://dx.doi.org/10.1182/blood-2010-12-322727.
31. Tarazona R, DelaRosa O, Alonso C, Ostos B, Espejo J, Peña J, Solana R. 2000. Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech. Ageing Dev. 121:77-88. http: //dx.doi.org/10.1016/S0047-6374(00)00199-8.
32. Buckheit RW, Salgado M, Silciano RF, Blankson JN. 2012. Inhibitory potential of subpopulations of CD8+ T cells in HIV-1-infected elite suppressors. J. Virol. 86:13679-13688. http://dx.doi.org/10.1128/JVI.02439-12.